Cheap NASDAQ Stocks - Invest Million

Citius Pharmaceuticals (NASDAQ: CTXR) To Raise $76.5 Million From Registered Direct Offering

Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) disclosed that it has signed a deal with institutional investors for the buying of a total of 50,830,566 shares of its common stock.

Breaking News

Novan (NASDAQ: NOVN) Drops Hard After Molluscum Contagiosum Trial Failed To Meet Primary Endpoints

Novan Inc. (NASDAQ: NOVN) was a big loser in Friday’s trading session. The stock gapped down and closed the day at a loss of 73.05%. This followed its announcement that, efficacy results from its Phase 3B program dubbed SIMPLE had not met

Cheap NASDAQ Stocks

Wave Life Sciences (NASDAQ: WVE) Drops After Disappointing Clinical Results For Huntington Disease Treatment

Wave Life Sciences Ltd (NASDAQ: WVE) was a big loser in yesterday’s trading session. The stock opened with a gap down to close the day at a loss of 49.46%. This followed news that, the company’s clinical results for its treatment

Cheap NASDAQ Stocks

Stealth BioTherapeutics (NASDAQ: MITO) Drops After Failed Treatment Trial for Primary Mitochondrial Myopathy

Stealth Biotherapeutics Corp (NASDAQ: MITO) was one of the big losers at the close of the week, after it dropped by 65.33%. This came after the company announced that, its late-stage trial for its investigational treatment for primary mitochondrial myopathy did not meet

Cheap NASDAQ Stocks

TransWorld Entertainment Corporation (NASDAQ: TWMC) Drops After Disappointing Q3 Results

TransWorld Entertainment Corporation (NASDAQ: TWMC) was one of the big losers in Wednesday’s trading session. The stock lost by 29.58% to close the day at $2.20. This came after the company released disappointing Q3 results. The company announced that total revenues

Cheap NASDAQ Stocks

OncoSec Medical Incorporated (NASDAQ: ONCS) Announces Interim Results For KEYNOTE-890

OncoSec Medical Incorporated (NASDAQ: ONCS) made a new low in Friday’s trading session, to close the day with losses of 16.18%. Nonetheless, the company made some positive announcement on that day. The company released interim results for KEYNOTE-890, which is a continuing

Cheap NASDAQ Stocks

Aldeyra Therapeutics (NASDAQ: ALDX) Gaps Down After Dry Eye Treatment Fails To Meet Goals

Aldeyra Therapeutics Inc (NASDAQ: ALDX) was one of the big stock losers in Tuesday’s trading session. The company closed the day at a loss of 32.44%. This followed news that investors were questioning the company’s dry eye treatment. This came after